A new study conducted at Brigham and Women’s Hospital in Boston in partnership with The Fenway Institute at Fenway Health will be using eTectRx’s ingestion event monitoring system to research adherence of the HIV prevention drug Truvada for pre-exposure prophylaxis (PrEP).
PrEP is a preventative drug designed to be taken by people who do not have HIV but are at risk for the condition. and must...
